# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Intrepid granted Bob Jornayvaz a temporary medical leave of absence, effective immediately, as he recovers from his previously ...
The company will provide updates as more information becomes available.
Intrepid Potash (NYSE:IPI) reported quarterly losses of $(0.410) per share which missed the analyst consensus estimate of $(0.0...
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...
BMO Capital analyst Joel Jackson maintains Intrepid Potash (NYSE:IPI) with a Market Perform and lowers the price target from...
Intrepid Potash (NYSE:IPI) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.10...